BrandName_2571

Category- Allopathy

Medicine Highlights

BrandName Uses

BrandName is an oral medicine belonging to the category of antidiabetic drugs and is used to manage type 2 diabetes mellitus.

BrandName side effects 

More Common

1. Nausea  
2. Diarrhea 
3. Constipation 
4. Abdominal pain 
5. Headache 
6. Dizziness 
7. Fatigue 

Less Common 

1. Hypoglycemia (especially when used with other medications) 
2. Swelling of the face, lips, or eyelids 
3. Heartburn 
4. Liver enzyme elevation 

How BrandName works 

BrandName works by acting in three ways: It stops the liver from producing excess sugar, increases the utilization of sugar in muscles, and protects the pancreas. At the same time, it looks after the tiny “power stations” inside our cells (mitochondria), so the body uses sugar more efficiently instead of letting it pile up in the blood. In simple terms, it helps the body handle sugar better from three directions less sugar made, more sugar used, and steadier insulin support. 

Safety Measures and Warning

Breastfeeding

Small amounts of BrandName pass into breast milk. Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Your healthcare provider will advise you if you should stop breastfeeding or stop BrandName.

Pregnancy

Due to a lack of studies on the effects of BrandName on the fetus, its safety is not clearly established. Therefore, if you are pregnant or planning to conceive, inform your doctor.

Kidney and Liver Problems

Patients suffering from kidney and liver problems are more prone to kidney and liver damage, as the drug is made into a less toxic form in the liver and kidney, so consult a doctor before using it.

BrandName Interaction with Food Product 

Avoid alcohol and smoking simultaneously, as they may affect the drug’s action and show an effect on blood glucose levels by affecting the liver and pancreas. It can sometimes increase blood sugar levels and sometimes decrease blood sugar levels.

BrandName Interaction with Other Medicines  

Avoid taking BrandName with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:

BrandName Chemical Structure

IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name

(2S)-N⁶,N⁶,2-trimethyl-1,2-dihydro-1,3,5-triazine-4,6-diamine

Intake routine/cycle

Daily dose

Take BrandName exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.

Overdose

It is not recommended to take more than 2000 mg of BrandName per day, as it may cause severe overdosing effects like extreme dizziness, confusion, low blood pressure, liver damage, low blood sugar levels, swelling, muscle damage, and seizures. Immediately give the patient fruit or glucose-containing liquids and sugary foods to minimize the effects.

Storage

1. Store the medicine at room temperature 
2. Keep away from sunlight and moisture 
3. Keep out of reach of children 

Directions for use 

1. Take BrandName exactly as prescribed by your doctor, at the same time each day. 
2. Do not stop taking BrandName without your doctor’s approval, even if you feel better. 
3. If you forget to take BrandName, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose. 

BrandName Summary 

BrandName is a new oral drug for type 2 diabetes (aminotriazine class) that lowers blood sugar by acting in three ways: by boosting insulin release, helping muscles use sugar better, and protecting cell’s powerhouses so sugar is burned, not stored. It’s mainly used when diet and exercise aren’t enough, with common side effects like mild stomach upset, nausea, or headache. It can be taken with food, but alcohol should be limited, and people with kidney or liver problems need extra care. In short, it’s a supportive partner that helps the body manage sugar more smoothly. BrandName has no fixed overdose limit, though doses up to 8000 mg/day have been tested safely; caution is essential in elderly, kidney or liver impaired, pregnant, breastfeeding, and pediatric patients.

FAQ’s

What is the maximum dose of BrandName per day?

It is not recommended to take more than 2000 mg of BrandName per day, as it may cause severe overdosing effects like extreme dizziness, confusion, low blood pressure, liver damage, low blood sugar levels, swelling, muscle damage, and seizures. Immediately give the patient fruit or glucose-containing liquids and sugary foods to minimize the effects.

What are the side effects of BrandName tablets?

BrandName is a pill taken by people with type 2 diabetes to help keep their blood sugar levels under control. Most people tolerate it well, but some may get common side effect like feeling tired or headaches or have minor stomach issues

What is the mechanism of action of BrandName ?

BrandName works as a three‑in‑one helper for type 2 diabetes: it reduces sugar production in the liver, helps muscles use sugar for energy, and supports the pancreas in releasing insulin, while also protecting the cell’s “power stations” (mitochondria) so sugar is burned efficiently instead of building up in the blood.

Reference 

1. PubChem. Imeglimin [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; [cited 2025 Sep 23]. Available from. 
2. True Meds. Imeglimin: View uses, side effects, and medicines [Internet]. Mumbai (IN): True meds India; [cited 2025 Sep 23]. Available from. 
3. Chevalier C, Fouqueray P, Bolze S. Imeglimin: A clinical pharmacology review. Clin Pharmacokinetics [Internet]. 2023 Sep 15;62(11):1393‑411. Available from. 
4. Fouqueray P, Pirags V, In Zucchi SE, Bailey CJ, Schernthaner G, Diamant M, et al. The efficacy and safety of imeglimin as add‑on therapy in type 2 diabetes inadequately controlled with metformin monotherapy: A multicenter, randomized, double‑blind, placebo‑controlled phase 3 trial. Diabetes Obes Metab [Internet]. 2021 May;23(5):1167‑76. Available from. 

Siva Krishna Adithya Bhumireddy

Siva Krishna Adithya Bhumireddy completed Bachelor of Pharmacy from GIET School of Pharmacy affiliated to Andhra University and from his 3rd year of graduation itself he was working as a freelance Medical and Publication writer and having expertise in Systematic reviews and clinical research. With his keen interest and skills in research and documentation practices he also reviewed more than 100 manuscripts from international journals like Elsevier, Springer Nature, Sage Journals and all the manuscripts were indexed and appeared in Pub Med, Scopus and Web of Science databases and received honorary recognition letters and certificates from all of them. Siva Krishna Adithya also published few systematic, narrative reviews and few chapters of international expertise.